首页> 外文期刊>Water Research >Elimination of pharmaceuticals in sewage treatment plants in Finland
【24h】

Elimination of pharmaceuticals in sewage treatment plants in Finland

机译:消除芬兰污水处理厂的药品

获取原文
获取原文并翻译 | 示例
           

摘要

The occurrence of eight Pharmaceuticals (β-blockers: acebutolol, atenolol, metoprolol and sotalol; antiepileptic: carbamazepine; fluoroquinolone antibiotics: ciprofloxacin, norflox-acin, ofloxacin) were assessed in the raw and treated sewage of 12 sewage treatment plants (STPs) in Finland. The average concentrations in the raw and treated sewage ranged from 100 to 1060 ng L~(-1) and from < 24 to 755 ng L~(-1), respectively. The average daily loads ranged from 36 to 405 mg/1000 inh and from 2 to 302 mg/1000 inh, respectively. In the treatment plants, fluoroquinolones were eliminated by > 80%. Carbamazepine was not eliminated during the treatment and in fact even higher concentrations were frequently found in the treated than in the raw sewages. The increase in concentration was shown to be most likely due to enzymatic cleavage of the glucuronic conjugate of carbamazepine and release of the parent compound in the treatment plant. The β-blockers were eliminated in average by less than 65% and the elimination varied greatly between the treatment plants. Especially the dilution of raw sewage by rainwater and a consequent decrease in the hydraulic retention time of a treatment plant was found to deteriorate the elimination of the β-blockers. The work shows that especially carbamazepine and the β-blockers may reach the recipient waters and there is a need to enhance their elimination in the sewage treatment plants. In this attempt, a denitrifying biofilter as a tertiary treatment could be of minor importance since in this study it did not result in further elimination of the target compounds.
机译:在12个污水处理厂(STP)的原始和处理后的污水中,评估了八种药物(β-阻滞剂:醋丁洛尔,阿替洛尔,美托洛尔和索他洛尔;抗癫痫药:卡马西平;氟喹诺酮抗生素:环丙沙星,诺氟沙星,氧氟沙星)的出现芬兰。生污水和处理后污水中的平均浓度分别为100至1060 ng L〜(-1)和<24至755 ng L〜(-1)。平均每日负荷分别为36至405 mg / 1000 inh和2至302 mg / 1000 inh。在处理厂中,氟喹诺酮类药物的消除率> 80%。在处理过程中未消除卡马西平,实际上,经处理的卡马西平的浓度通常高于未处理污水中的浓度。浓度的增加最有可能是由于卡马西平的葡糖醛酸结合物的酶促裂解和母体化合物在处理植物中的释放。 β受体阻滞剂的平均消除率不到65%,并且在不同的处理厂之间消除率差异很大。特别是,发现雨水稀释了原始污水,并因此减少了处理设备的水力停留时间,这会降低β受体阻滞剂的清除率。这项工作表明,尤其是卡马西平和β受体阻滞剂可能会到达接收者的水域,因此有必要在污水处理厂中进一步消除它们。在此尝试中,将脱氮生物滤池作为第三级处理的重要性不高,因为在本研究中,它并未导致目标化合物的进一步消除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号